the related peptide afamelanotide (Scenesse) is FDA-approved for erythropoietic protoporphyria
Accumulated evidence suggests that long term treatment with GLP-1 receptor agonist is associated with a reduction in measured glomerular filtration rate (GFR), preservation of renal function and/or a decrease in the incidence of cardiovascular events
GLP-1 from dietary sources has a very short half life compared to GLP-1 half life from medications
They can adopt various phenotypes, such as the inflammatory-promoting M1 subtype and the inflammation-suppressing M2 phenotype, and secrete different inflammatory mediators in response to inflammation [102,103,104]
This ripple effect contributes to statewide demand
It is a natural compound that can be synthesized in the body from essential amino acids lysine and methionine or obtained through the diet, primarily stored in skeletal muscles